IP Library Granted Patent US 12,173,275
Granted Patent B2
US 12,173,275 · App. 18/305,068 · Granted Dec 24, 2024

Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms

Inventors: Holger Klapproth (Freiburg, DE); Nicolaas Smit (Welland, CA)
Assignee: SAFEGUARD BIOSYSTEMS HOLDINGS LTD.
C12N1/066B01L3/5082C12N15/1006G01N1/286C12N2509/10G01N2001/2866
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,173,275
App. No.
18/305,068
Granted
Dec 24, 2024
Kind
B2
Abstract

The present disclosure provides improved methods for bead beating and a bead beating system useful therefor. The present disclosure further provides methods of using the bead beating system to extract nucleic acids from cells containing the nucleic acids.

Claims (26)

1. A method for producing a lysate from cells contained in blood containing an anticoagulant, comprising:

agitating the blood within a bead beating system in the absence of any additive other than the anticoagulant, under conditions sufficient to lyse both a fungal pathogen and a bacterial pathogen and provide a lysate suitable for PCR amplification of DNA from the fungal pathogen, when present, and the bacterial pathogen, when present, said bead beating system comprising (i) a sample tube or blood collection tube and (ii) beads.

2. The method of claim 1 , wherein the beads are adapted to lyse yeast or filamentous fungi.

3. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Candida albicans and (ii) provide a lysate suitable for PCR amplification of DNA from Candida albicans , when the Candida albicans is present.

4. The method of claim 3 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.

5. The method of claim 4 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

6. The method of claim 3 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

7. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.

8. The method of claim 7 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

9. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

10. The method of claim 1 , wherein the agitating comprises subjecting the bead beating system to an oscillating motion.

11. The method of claim 1 , wherein the agitating is performed with a vortexer or a homogenizer.

12. The method of claim 1 , wherein the agitating comprises subjecting the bead beating system to 2000 or more oscillations per minute.

13. The method of claim 1 , wherein the agitating is performed for 25-60 seconds.

14. The method of claim 1 , wherein the agitating is performed for 1-2 minutes.

15. The method of claim 1 , wherein the anticoagulant is EDTA, citrate, oxalate or heparin.

16. The method of claim 1 , wherein the cells comprise one or more pathogens.

17. The method of claim 16 , wherein the cells comprise one or more bacterial pathogens, viral pathogens, fungal pathogens, or a combination thereof.

18. The method of claim 17 , wherein the cells comprise one or more fungal pathogens.

19. The method of claim 18 , wherein the one or more fungal pathogens comprise Candida albicans.

20. The method of claim 17 , wherein the cells comprise one or more bacterial pathogens.

21. The method of claim 20 , wherein the one or more bacterial pathogens comprise Staphylococcus aureus.

22. The method of claim 20 , wherein the one or more bacterial pathogens comprise Escherichia coli.

23. The method of claim 1 , wherein the blood comprises cells from multiple species.

24. The method of claim 1 , further comprising purifying one or more nucleic acids from the lysate.

25. The method of claim 1 , further comprising analyzing one or more nucleic acids from the lysate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2024
From: SAFEGUARD BIOSYSTEMS HOLDING LIMITED
To: SAFEGUARD DX LIMITED
Reel/Frame 069088/0245 →
Priority Claims (1)
EP 2017051902 · Jan 30, 2017 · regional
Continuity (3)
Continuation 16487769
Provisional Application 62538073 · Jul 28, 2017
Related Publication 20230383242A1 · Nov 30, 2023